Alan Stewart Acquires 33,923 Shares of Haleon plc (LON:HLN) Stock

Haleon plc (LON:HLN) insider Alan Stewart acquired 33,923 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was bought at an average price of GBX 368 ($4.79) per share, for a total transaction of £124,836.64 ($162,505.39).

Haleon Price Performance

HLN stock opened at GBX 362.27 ($4.72) on Friday. The stock has a market capitalization of £32.75 billion, a price-to-earnings ratio of 3,014.17, a PEG ratio of 1.49 and a beta of 0.19. The firm’s 50-day moving average price is GBX 383.91 and its two-hundred day moving average price is GBX 354.82. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 54.18. Haleon plc has a 12-month low of GBX 308.37 ($4.01) and a 12-month high of GBX 400.65 ($5.22).

Wall Street Analyst Weigh In

Separately, Berenberg Bank lifted their price target on Haleon from GBX 410 ($5.34) to GBX 447 ($5.82) and gave the stock a “buy” rating in a research note on Monday, August 5th.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.